Share this post on:

Product Name :
NMP

Search keywords :
Interferon Regulatory Factor 4

drugId :
null

Target Vo:
Interferon regulatory factor 4

Target Vo Short Name :
IRF-4

Moa_Name:
Interferon regulatory factor 4 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Peter Maccallum Cancer Centre

Active Company_Name :
Peter Maccallum Cancer Centre

Active Indication_Name:
Hematologic Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Rad51 Antibody
MMP3 Antibody
YAP1 Antibody: YAP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to YAP1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human.

Share this post on:

Author: Betaine hydrochloride